A new device for interstitial 125Iodine seed implantation

Area of Science:

• Medical Devices
• Radiation Oncology
• Surgical Technology

Background:

• Interstitial brachytherapy using Iodine-125 (I-125) seeds is a key treatment modality for various tumors.
• Existing commercial systems for seed implantation present challenges in terms of complexity, speed, and safety.
• The need for improved devices for precise and efficient radioactive seed delivery is critical in oncological treatment.

Purpose of the Study:

• To introduce and describe a new device for the interstitial implantation of I-125 seeds.
• To evaluate the technical details, functionality, and performance of the novel system.
• To compare the new device with established commercial systems for interstitial brachytherapy.

Main Methods:

• Detailed description of the device's unique design and operational mechanics.
• Comparative analysis of the new device against well-known commercial brachytherapy systems.
• Radiation measurements conducted to assess patient and personnel exposure during implantation procedures.

Main Results:

• The new device demonstrates a unique design enabling simple, fast, and safe implantation of I-125 seeds.
• The system is suitable for treating a wide range of tumor sites, including stereotactic brain implantation.
• Radiation measurements confirmed low exposure levels for both patients and healthcare personnel.

Conclusions:

• The presented device offers a significant advancement in interstitial brachytherapy for I-125 seed implantation.
• Its ease of use, speed, and safety profile make it a valuable tool for treating diverse tumor locations.
• The device contributes to safer brachytherapy practices by minimizing radiation exposure.